Bioavailability of a small unilamellar low-clearance liposomal amikacin formulation after extravascular administration

Journal of Drug Targeting

Volumn 6, Issue 6, 1999, Pages 415-426

  Fielding, R M ^a,b   Moon McDermott, L ^a   Lewis, R O ^a  

^a GILEAD SCIENCES   (United States)

^b Biologistic Services Boulder   (United States)

Author keywords

Amikacin; Intramuscular; Intraperitoneal; Intratracheal; Liposomes; Subcutaneous

Indexed keywords

AMIKACIN; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; ENCAPSULATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032879595     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869908996848     Document Type: Article

References (19)

1. Allen, T.M., Hansen, C.B. and Guo, L.S. (1993) Subcutaneous administration of liposomes, a comparison with the intravenous and intraperitoneal routes of injection. Biochim. Biophys. Acta, 1150, 9-16.
2. al-Suwayeh, S.A., Tebbet, I.R., Wielbo, D. and Brazeau, G.A. (1996) In vitro-in vivo myotoxicity of intramuscular liposomal formulations. Pharm. Res., 13, 1384-1388.
3. Cabanes, A., Reig, F., Anton, J.M. and Arboix, M. (1995) Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits. Am. J. Vet. Res., 56, 1498-1501.
4. Eng, E.T. (1996) Prophylactic and therapeutic treatment of Gram-negative septicemia with liposomal and non-liposomal encapsulated amikacin in immunocompromised mice. Thesis presented to California State Polytechnic University, Pomona, CA.
5. Fielding, R.M. and Abra, R.M. (1991) Factors affecting the release rate of terbutaline from liposome formulations after intratracheal instillation in the guinea pig. Pharm. Res., 9, 220-223.
6. Fielding, R.M., Lewis, R.O. and Moon-McDermott, L. (1998a) Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome®). Pharm. Res., 15, 1775-1781.
7. Fielding, R.M., Mukwaya, G. and Sandhaus, R.A. (1998b) Clinical and preclinical studies with low-clearance liposomal Amikacin (MiKasome®). In Woodle, M.C. and Storm, G. (Ed.), Long-Circulating Liposomes: Old Drugs, New Therapeutics (Berlin: Springer-Verlag), Chapter 15.
8. Fielding, R.M., Moon-McDermott, L., Lewis, R.O. and Horner, M.J. (1999) Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey. Antimicrob. Agents Chemother., 43, 503-509.
9. Hirano, K. and Hunt, C.A. (1985) Lymphatic transport of liposome-encapsulated agents, effects of liposome size following intraperitoneal administration. J. Pharm. Sci., 74, 915-921.
10. Jackson, A.J. (1981) Intramuscular absorption and regional lymphatic uptake of liposome-entrapped inulin. Drug Metab. Dispos., 9, 535-540.
11. Karlowsky, J.A. and Zhanel, G.G. (1992) Concepts on the use of liposomal antimicrobial agents: applications for aminoglycosides. Clin. Infect. Dis., 15, 654-667.
12. Kim, C.K. and Han, J.H. (1995) Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats. J. Microencapsul., 12, 437-446.
13. Oussoren, C., Zuidema, J., Crommelin, D.J. and Storm, G. (1997) Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid composition and lipid dose. Biochim. Biophys. Acta, 1328, 261-272.
14. Phillips, N.C., Loutfi, A., A-Kareem, A.M., Shibata, H.R. and Baines, M.G. (1990) Clinical evaluation of liposomal tumor antigen vaccines in patients with stage-III melanoma. Cancer Detect. Prev., 14, 491-496.
15. Price, C.I., Horton, J.W. and Baxter, C.R. (1989) Enhanced effectiveness of intraperitoneal antibiotics administered via liposomal carrier. Arch. Surg., 124, 1411-1414.
16. Tilney, N. (1971) Patterns of lymphatic drainage in the adult laboratory rat. J. Anat., 109, 369-383.
17. Tümer, A., Kirby, C., Senior, J. and Gregoriadis, G. (1983) Fate of cholesterol-rich liposomes after subcutaneous injection into rats. Biochim. Biophys. Acta, 760, 119-125.
18. Valladares, J.E., Freixas, J., Alberola, J., Franquelo, C., Cristofol, C. and Arboix, M. (1997) Pharmacokinetics of liposome-encapsulated meglumine antimonate after intramuscular and subcutaneous administration in dogs. Am. J. Trop. Med. Hyg., 57, 403-406.
19. Zaske, D.E. (1992) Aminoglycosides. In Evans, W.E., Schentag, J.J. and Jusko, W.J. (Eds.), Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring (Vancouver, WA: Applied Therapeutics, Inc.), Chapter 14.